Gabapentin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76420-014 -
Package NDC
76420-014-30 -
Application number
ANDA075350 -
SPL ID
ead11d10-7482-8d9b-e053-2a95a90a2c68 -
SPL set ID
e89a7ff2-bd82-4fde-b2b7-3b9d0edf6fc8 -
UNII
6CW7F3G59X -
RxCUI
310430 -
RxCUI
310431
What the source publishes
- Labeler
- Asclemed USA, Inc.
- Active ingredients
- Gabapentin
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Gabapentin",
"splId": "ead11d10-7482-8d9b-e053-2a95a90a2c68",
"labels": [
{
"setId": "e89a7ff2-bd82-4fde-b2b7-3b9d0edf6fc8",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e89a7ff2-bd82-4fde-b2b7-3b9d0edf6fc8",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e89a7ff2-bd82-4fde-b2b7-3b9d0edf6fc8"
}
],
"routes": [
"ORAL"
],
"labeler": "Asclemed USA, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 CAPSULE in 1 BOTTLE (76420-014-30)",
"package_ndc": "76420-014-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20200123"
}
],
"productId": "76420-014_ead11d10-7482-8d9b-e053-2a95a90a2c68",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "76420-014",
"deaSchedule": null,
"genericName": "Gabapentin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "GABAPENTIN",
"strength": "100 mg/1"
}
],
"applicationNumber": "ANDA075350",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140423",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486"
],
"unii": [
"6CW7F3G59X"
],
"rxcui": [
"310430",
"310431"
],
"spl_set_id": [
"e89a7ff2-bd82-4fde-b2b7-3b9d0edf6fc8"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"manufacturer_name": [
"Asclemed USA, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76420-014_ead11d10-7482-8d9b-e053-2a95a90a2c68"